Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 2 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report.
J Neurol. 2024 Apr 11. doi: 10.1007/s00415-024-12367-4. Online ahead of print.
J Neurol. 2024.
PMID: 38602546
No abstract available.
Refractory generalized myasthenia gravis treated successfully with telitacicept: two cases report.
Zhang Z, Wang Z, Du X, Huang X, Zhang Y.
Zhang Z, et al.
J Neurol. 2024 Jan;271(1):584-588. doi: 10.1007/s00415-023-12036-y. Epub 2023 Oct 7.
J Neurol. 2024.
PMID: 37804335
No abstract available.
Item in Clipboard
Cite
Cite